Introduction: Contingency management (CM) is an efficacious treatment for stimulant use disorders. Support materials for the clinical delivery of prize-based CM are widely accessible, but few resources are available to support design and preparation for CM implementation. This guide aims to fill that gap.
Method/results: The article outlines a suggested prize CM protocol and discusses the best practices most aligned with the evidence base and acceptable-if-necessary modifications. This guide also highlights modifications that are not evidence-based and not recommended. In addition, I discuss practical and clinical aspects of preparing for CM implementation.
Conclusions: Deviations from evidence-based practices are common, and poorly designed CM is unlikely to impact patient outcomes. This article provides planning stage guidance to support programs' adoption of evidence-based prize CM for the treatment of stimulant use disorders.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10330855 | PMC |
| http://dx.doi.org/10.1016/j.josat.2023.209079 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Arriba y Adelante: Looking Outward and Moving Ahead.
Phys Ther
December 2024
Department of and Rehabilitation and Movement Sciences, Rutgers University, Newark, NJ, United States.
Judith E. Deutsch, PT, PhD, FAPTA, the 55th McMillan Lecturer, is professor and director of the Research in Virtual Environments and Rehabilitation Sciences (Rivers) Lab in the Doctoral Programs in Physical Therapy in the School of Health Professions at Rutgers University. Her current research includes the development and testing of virtual reality, serious games to improve mobility and fitness of individuals with neurologic health conditions, and knowledge translation to strengthen evidence-based practice.
View Article and Find Full Text PDFWake Smiles Prizes Dignity and Empathy Alongside Evidence-based Oral Health Care.
N C Med J
August 2024
Wake Smiles, Raliegh, NC.
Examining the impact of low magnitude incentives in contingency management protocols: Non-engagement in Petry et al. 2004.
J Subst Use Addict Treat
December 2024
University of Connecticut School of Medicine, Calhoun Cardiology Center, United States of America; University of Connecticut School of Medicine, Department of Medicine, United States of America; University of Connecticut School of Medicine, Department of Psychiatry, United States of America.
Article Synopsis
- Current federal regulations limit contingency management (CM) incentives to $75 per patient per year, which is significantly lower than the amounts used in effective treatment protocols, such as those evaluated in a 2004 study by Petry et al.
- A re-analysis of this study indicated that the higher incentive of $240 was effective in improving abstinence outcomes, whereas the lower incentive of $80 was not, suggesting that it led to higher rates of non-engagement with treatment.
- The findings advocate against the federal limit on CM incentives, proposing that evidence-based protocols be utilized instead, alongside necessary regulatory changes to enable their implementation.
Twenty-Four Hour Glucose Profiles and Glycemic Variability during Intermittent Religious Dry Fasting and Time-Restricted Eating in Subjects without Diabetes: A Preliminary Study.
Nutrients
August 2024
Department of Molecular Metabolism and Precision Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany.
Intermittent religious fasting increases the risk of hypo- and hyperglycemia in individuals with diabetes, but its impact on those without diabetes has been poorly investigated. The aim of this preliminary study was to examine the effects of religious Bahá'í fasting (BF) on glycemic control and variability and compare these effects with time-restricted eating (TRE). In a three-arm randomized controlled trial, 16 subjects without diabetes were assigned to a BF, TRE, or control group.
View Article and Find Full Text PDFEfficacy and acceptability of interventions to reduce antipsychotic polypharmacy: A systematic review and meta-analysis of randomized clinical trials.
Schizophr Res
August 2024
German Center for Mental Health (DZPG), Berlin, Germany; Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
Background: Antipsychotic polypharmacy (APP) is frequent but evidence-based guidelines on reducing APP to antipsychotic monotherapy (APM) are sparse. We aimed to systematically review clinical interventions randomizing patients to reducing APP to APM versus continuing APP.
Methods: Systematic literature review searching Medline and Embase (latest search January 10, 2024) for randomized clinical trials (RCTs) studying interventions comparing individuals randomized to reduction of APP to APM with individuals continuing on APP.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!